Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke

Brain Research

Volumn 1624, Issue , 2015, Pages 489-496

  Zhao, Qiuchen ^a   Hu, Jinxia ^b   Xiang, Jie ^b   Gu, Yuming ^b   Jin, Peisheng ^c   Hua, Fang ^b   Zhang, Zunsheng ^b   Liu, Yonghai ^b   Zan, Kun ^b   Zhang, Zuohui ^b   Zu, Jie ^b   Yang, Xinxin ^b   Shi, Hongjuan ^b   Zhu, Jienan ^b   Xu, Yun ^a   Cui, Guiyun ^b   Ye, Xinchun ^b  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c XUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Angiopoietin; Conditioned medium; Human umbilical cord mesenchymal stem cells; Intranasal administration; Vascular remodeling

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; CONDITIONED MEDIUM; DESMIN; PROTEIN ZO1; TJP1 PROTEIN, RAT; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN; VON WILLEBRAND FACTOR;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL INJURY; CELL THERAPY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL RATE; UMBILICAL CORD; VASCULAR REMODELING; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; CHEMISTRY; CONDITIONED MEDIUM; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS BLOOD; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRANASAL DRUG ADMINISTRATION; MESENCHYMAL STROMA CELL; METABOLISM; NEUROLOGIC EXAMINATION; PATHOLOGY; PHARMACOLOGY;

ADMINISTRATION, INTRANASAL; ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DESMIN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETAL BLOOD; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MESENCHYMAL STROMAL CELLS; NEUROLOGIC EXAMINATION; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR REMODELING; VON WILLEBRAND FACTOR; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84954237574     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.08.003     Document Type: Article

References (39)

1. L.S. Barcelos, C. Duplaa, N. Krankel, G. Graiani, G. Invernici, R. Katare, M. Siragusa, M. Meloni, I. Campesi, M. Monica, A. Simm, P. Campagnolo, G. Mangialardi, L. Stevanato, G. Alessandri, C. Emanueli, and P. Madeddu Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling Circ. Res. 104 2009 1095 1102
2. L. Cai, B.H. Johnstone, T.G. Cook, J. Tan, M.C. Fishbein, P.S. Chen, and K.L. March IFATS collection: human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function Stem Cells 27 2009 230 237
3. L. Calza, L. Giardino, A. Giuliani, L. Aloe, and R. Levi-Montalcini Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors Proc. Natl. Acad. Sci. USA 98 2001 4160 4165
4. J. Chen, P.R. Sanberg, Y. Li, L. Wang, M. Lu, A.E. Willing, J. Sanchez-Ramos, and M. Chopp Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats Stroke 32 2001 2682 2688
5. J. Chen, Z.G. Zhang, Y. Li, L. Wang, Y.X. Xu, S.C. Gautam, M. Lu, Z. Zhu, and M. Chopp Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats Circ. Res. 92 2003 692 699
6. J. Chen, X. Ye, T. Yan, C. Zhang, X.-P. Yang, X. Cui, Y. Cui, A. Zacharek, C. Roberts, X. Liu, X. Dai, M. Lu, and M. Chopp Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats Stroke 42 2011 3551 3558
7. Y.J. Cho, H.S. Song, S. Bhang, S. Lee, B.G. Kang, J.C. Lee, J. An, C.I. Cha, D.H. Nam, B.S. Kim, and K.M. Joo Therapeutic effects of human adipose stem cell-conditioned medium on stroke J. Neurosci. Res. 90 2012 1794 1802
8. G. Cui, X. Ye, T. Zuo, H. Zhao, Q. Zhao, W. Chen, and F. Hua Chloroquine pretreatment inhibits toll-like receptor 3 signaling after stroke Neurosci. Lett. 548 2013 101 104
9. G. Cui, T. Zuo, Q. Zhao, J. Hu, P. Jin, H. Zhao, J. Jing, J. Zhu, H. Chen, B. Liu, F. Hua, and X. Ye ROCK mediates the inflammatory response in thrombin induced microglia Neurosci. Lett. 554 2013 82 87
10. X. Cui, M. Chopp, A. Zacharek, X. Ye, C. Roberts, and J. Chen Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke Neurobiol. Dis. 43 2011 285 292
11. S. Di Santo, Z. Yang, M. Wyler von Ballmoos, J. Voelzmann, N. Diehm, I. Baumgartner, and C. Kalka Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation PLoS One 4 2009 e5643
12. S. Hori, S. Ohtsuki, K. Hosoya, E. Nakashima, and T. Terasaki A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro J. Neurochem. 89 2004 503 513
13. T. Inoue, M. Sugiyama, H. Hattori, H. Wakita, T. Wakabayashi, and M. Ueda Stem cells from human exfoliated deciduous tooth-derived conditioned medium enhance recovery of focal cerebral ischemia in rats Tissue Eng. Part A 19 2013 24 29
14. T. Ishrat, I. Sayeed, F. Atif, and D.G. Stein Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats Brain Res. 1257 2009 94 101
15. T. Kinnaird, E. Stabile, M.S. Burnett, C.W. Lee, S. Barr, S. Fuchs, and S.E. Epstein Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ. Res. 94 2004 678 685
16. S.H. Koh, K.S. Kim, M.R. Choi, K.H. Jung, K.S. Park, Y.G. Chai, W. Roh, S.J. Hwang, H.J. Ko, Y.M. Huh, H.T. Kim, and S.H. Kim Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats Brain Res. 1229 2008 233 248
17. Y. Li, N. Jiang, C. Powers, and M. Chopp Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats Stroke 29 1998 1972 1980 (discussion 1980-1)
18. Y.C. Lin, T.L. Ko, Y.H. Shih, M.Y. Lin, T.W. Fu, H.S. Hsiao, J.Y. Hsu, and Y.S. Fu Human umbilical mesenchymal stem cells promote recovery after ischemic stroke Stroke 42 2011 2045 2053
19. M. Lu, J. Chen, D. Lu, L. Yi, A. Mahmood, and M. Chopp Global test statistics for treatment effect of stroke and traumatic brain injury in rats with administration of bone marrow stromal cells J. Neurosci. Methods 128 2003 183 190
20. 3rd, C.S. Moy, P. Muntner, M.E. Mussolino, K. Nasir, R.W. Neumar, G. Nichol, L. Palaniappan, D.K. Pandey, M.J. Reeves, C.J. Rodriguez, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, J.Z. Willey, D. Woo, R.W. Yeh, M.B. Turner, C. American Heart Association Statistics, and S. Stroke Statistics Heart disease and stroke statistics - 2015 update: a report from the American Heart Association Circulation 131 2015 e29 322
21. N. Nourhaghighi, K. Teichert-Kuliszewska, J. Davis, D.J. Stewart, and S. Nag Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis Lab. Investig. 83 2003 1211 1222
22. E.C. Perin, and G.V. Silva Autologous cell-based therapy for ischemic heart disease: clinical evidence, proposed mechanisms of action, and current limitations Catheter. Cardiovasc. Interv. 73 2009 281 288
23. R. Sandhu, K. Teichert-Kuliszewska, S. Nag, G. Proteau, M.J. Robb, A.I. Campbell, M.A. Kuliszewski, M.J. Kutryk, and D.J. Stewart Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat Cardiovasc. Res. 64 2004 115 124
24. T.N. Sato, Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, T. Gridley, H. Wolburg, W. Risau, and Y. Qin Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation Nature 376 1995 70 74
25. S. Sell On the stem cell origin of cancer Am. J. Pathol. 176 2010 2584 24494
26. J. Stagg Mesenchymal stem cells in cancer Stem Cell Rev. 4 2008 119 124
27. C. Suri, P.F. Jones, S. Patan, S. Bartunkova, P.C. Maisonpierre, S. Davis, T.N. Sato, and G.D. Yancopoulos Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis Cell 87 1996 1171 1180
28. C. Suri, J. McClain, G. Thurston, D.M. McDonald, H. Zhou, E.H. Oldmixon, T.N. Sato, and G.D. Yancopoulos Increased vascularization in mice overexpressing angiopoietin-1 Science 282 1998 468 471
29. R.G. Thorne, and W.H. Frey 2nd Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations Clin. Pharmacokinet. 40 2001 907 946
30. G. Thurston, J.S. Rudge, E. Ioffe, H. Zhou, L. Ross, S.D. Croll, N. Glazer, J. Holash, D.M. McDonald, and G.D. Yancopoulos Angiopoietin-1 protects the adult vasculature against plasma leakage Nat. Med. 6 2000 460 463
31. L. Tian, R. Guo, X. Yue, Q. Lv, X. Ye, Z. Wang, Z. Chen, B. Wu, G. Xu, and X. Liu Intranasal administration of nerve growth factor ameliorate beta-amyloid deposition after traumatic brain injury in rats Brain Res. 1440 2012 47 55
32. X. Ye, M. Chopp, X. Cui, A. Zacharek, Y. Cui, T. Yan, A. Shehadah, C. Roberts, X. Liu, M. Lu, and J. Chen Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats Exp. Neurol. 232 2011 299 308
33. X. Ye, M. Chopp, X. Liu, A. Zacharek, X. Cui, T. Yan, C. Roberts, and J. Chen Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats Neuroscience 190 2011 339 345
34. B.S. Yoon, J.H. Moon, E.K. Jun, J. Kim, I. Maeng, J.S. Kim, J.H. Lee, C.S. Baik, A. Kim, K.S. Cho, J.H. Lee, H.H. Lee, K.Y. Whang, and S. You Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells Stem Cells Dev. 19 2010 887 902
35. H. Yu, P. Wang, P. An, and Y. Xue Recombinant human angiopoietin-1 ameliorates the expressions of ZO-1, occludin, VE-cadherin, and PKCalpha signaling after focal cerebral ischemia/reperfusion in rats J. Mol. Neurosci. 46 2012 236 247
36. A. Zacharek, A. Shehadah, J. Chen, X. Cui, C. Roberts, M. Lu, and M. Chopp Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment Stroke 41 2010 524 530
37. Z.G. Zhang, L. Zhang, W. Tsang, H. Soltanian-Zadeh, D. Morris, R. Zhang, A. Goussev, C. Powers, T. Yeich, and M. Chopp Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia J. Cereb Blood Flow Metab. 22 2002 379 392
38. J. Zhu, Y. Jiang, G. Xu, and X. Liu Intranasal administration: a potential solution for cross-BBB delivering neurotrophic factors Histol. Histopathol. 27 2012 537 548
39. S.F. Zhu, Z.N. Zhong, X.F. Fu, D.X. Peng, G.H. Lu, W.H. Li, H.Y. Xu, H.B. Hu, J.M. He, W.Y. Su, and Y.L. He Comparison of cell proliferation, apoptosis, cellular morphology and ultrastructure between human umbilical cord and placenta-derived mesenchymal stem cells Neurosci. Lett. 541 2013 77 82